menu search

Crinetics to highlight broad pipeline at endo 2023

Endocrine Society President to Present Crinetics CEO with John D. Baxter Prize for Entrepreneurship SAN DIEGO, June 09, 2023 (GLOBE NEWSWIRE) — Crin...

June 9, 2023, 11:30 am

Inovio pharmaceuticals, inc. (ino) jefferies healthcare conference 2023 (transcript)

Inovio pharmaceuticals, Inc. (NASDAQ:INO ) Jefferies Healthcare Conference 2023 June 9, 2023 8:00 PM ET...

June 9, 2023, 10:17 am

Ny ag approves $17.3 billion opioid settlement with cvs, walgreens, teva and abbvie's allergan

New York Attorney General Letitia James announced Friday the final approval of $17.3 billion in national settlement agreements with drug-store chains ...

June 9, 2023, 10:09 am

White house signals no pause on medicare drug price negotiations after merck lawsuit

The Biden administration on Thursday indicated no pause in its timeline for Medicare drug price negotiations in the wake of a legal challenge from ...

June 9, 2023, 8:38 am

Packaging printing market to rise from usd 410 billion in 2023 to usd 600 billion by 2030, exhibiting growth at a rate of 8.00% from 2023 to 2030 – report by market research future (mrfr)

Packaging Printing Market Research Report Information By Printing Technology (Flexography, Gravure, and Digital), by Application (Food & Beverage, Per...

June 9, 2023, 6:42 am

Top pharmaceutical and ancillary cannabis stocks for june 2023

Do you intend to invest in marijuana stocks in 2023?  Over the last decade, the cannabis industry has grown incredibly, transitioning from a taboo su...

June 8, 2023, 4:50 pm

Teva pharmaceutical settles $193m opioid suit with the state of nevada

Teva pharmaceutical Industries (NASDAQ:TEVA) has agreed to pay the state of Nevada $193 million to sett...

June 8, 2023, 12:34 pm

Teva concludes nationwide opioid settlement agreement, reaches separate settlement with nevada

Teva pharmaceuticals TEVA, +2.07% announced Thursday that it has resolved its nationwide settlement agr...

June 8, 2023, 8:53 am

Rocket pharmaceuticals shares rise on fda fast-track designation for heart disease treatment

Shares of Rocket pharmaceuticals RCKT, +0.17% gained 2.3% premarket on Thursday after the late-stage bi...

June 8, 2023, 8:25 am

Bridgebio pharma to present updated six month results from its phase 2 cohort 5 study of infigratinib in achondroplasia in a late breaker oral presentation at the endocrine society (endo) 2023 annual

PALO ALTO, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...

June 8, 2023, 7:30 am

Bridgebio pharma to present updated six month results from its phase 2 cohort 5 study of infigratinib in achondroplasia in a late breaker oral presentation at the endocrine society (endo) 2023 annual

PALO ALTO, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...

June 8, 2023, 7:30 am

Bridgebio pharma to present updated six month results from its phase 2 cohort 5 study of infigratinib in achondroplasia in a late breaker oral presentation at the endocrine society (endo) 2023 annual

PALO ALTO, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...

June 8, 2023, 7:30 am

Bridgebio pharma to present updated six month results from its phase 2 cohort 5 study of infigratinib in achondroplasia in a late breaker oral presentation at the endocrine society (endo) 2023 annual

PALO ALTO, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...

June 8, 2023, 7:30 am

Bridgebio pharma to present updated six month results from its phase 2 cohort 5 study of infigratinib in achondroplasia in a late breaker oral presentation at the endocrine society (endo) 2023 annual

PALO ALTO, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...

June 8, 2023, 7:30 am

Oxford cannabinoid appoints chief medical officer

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) has appointed Dr Tim Corn as the new Chief Medical Officer (CMO), effective imme...

June 8, 2023, 2:32 am

Cell dissociation market set to top a valuation of us$ 1257.59 million by 2033 & exhibit a cagr of 13.55% over the forecast period | future market insights, inc.

Cell dissociation, also known as trypsinization, is the process of separating adherent cells from the cell culture vessel by breaking down proteins wi...

June 8, 2023, 12:30 am

Ultragenyx to participate in the goldman sachs 44th annual global healthcare conference

NOVATO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — Ultragenyx pharmaceutical Inc. (NASDAQ: RARE), a bio...

June 7, 2023, 9:00 pm

Rhythm pharmaceuticals: putting it on the scale again

Today, we check back in on Rhythm pharmaceuticals, Inc., an entrant into the fast-growing weight manage...

June 7, 2023, 7:08 pm

Teva to pay nevada $193 million over role in opioid epidemic

Teva pharmaceutical Industries on Wednesday agreed to pay Nevada $193 million to settle claims that its...

June 7, 2023, 5:15 pm

Geron to participate in goldman sachs 44th annual global healthcare conference

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutica...

June 7, 2023, 4:30 pm


Search within

Pages Search Results: